Form 8-K - Current report:
SEC Accession No. 0000950123-04-014337
Filing Date
2004-12-02
Accepted
2004-12-02 14:47:58
Documents
2
Period of Report
2004-11-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y69294e8vk.txt 8-K 4451
2 PRESS RELEASE y69294exv99w1.txt EX-99.1 24587
  Complete submission text file 0000950123-04-014337.txt   30923
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 041180251
SIC: 2835 In Vitro & In Vivo Diagnostic Substances